Cargando…

Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis

OBJECTIVE: Serum p53 autoantibodies (p53-AAbs) are the product of an endogenous immune response against p53 overexpression driven by the ovarian tumour. The p53-AAbs are detectable only in a subset of patients. To date, the evidence of an association between the presence of p53-AAbs and ovarian canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garziera, Marica, Montico, Marcella, Bidoli, Ettore, Scalone, Simona, Sorio, Roberto, Giorda, Giorgio, Lucia, Emilio, Toffoli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599823/ https://www.ncbi.nlm.nih.gov/pubmed/26451959 http://dx.doi.org/10.1371/journal.pone.0140351

Ejemplares similares

New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach
por: Garziera, Marica, et al.
Publicado: (2019)

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
por: Garziera, Marica, et al.
Publicado: (2019)

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
por: Garziera, Marica, et al.
Publicado: (2018)

Paraneoplastic cerebellar degeneration associated with ovarian cancer
por: RUSSO, ALESSIA ERIKA, et al.
Publicado: (2013)

Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells
por: Garziera, Marica, et al.
Publicado: (2017)

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
por: Bartoletti, Michele, et al.
Publicado: (2020)

Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study
por: Giorda, Giorgio, et al.
Publicado: (2014)

Soluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategy
por: Scarabel, Lucia, et al.
Publicado: (2020)

HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment
por: Garziera, Marica, et al.
Publicado: (2015)

An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer
por: Bartoletti, Michele, et al.
Publicado: (2022)

Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study
por: Veronesi, Andrea, et al.
Publicado: (2010)

HLA-G 3′UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer
por: Garziera, Marica, et al.
Publicado: (2017)

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring
por: Canil, Giovanni, et al.
Publicado: (2023)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

The oncogenic and prognostic role of PDK1 in the progression and metastasis of ovarian cancer
por: Yao, Shasha, et al.
Publicado: (2021)

Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer
por: Zanusso, Chiara, et al.
Publicado: (2017)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2014)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2013)

Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis
por: De Mattia, Elena, et al.
Publicado: (2023)

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients
por: Iacuzzi, Valentina, et al.
Publicado: (2019)

Molecular Signature in HCV-Positive Lymphomas
por: De Re, Valli, et al.
Publicado: (2012)

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients
por: Miolo, Gianmaria, et al.
Publicado: (2014)

How TP53 (almost) became an oncogene
por: Weinberg, Robert A
Publicado: (2019)

Do Mutations Turn p53 into an Oncogene?
por: Pitolli, Consuelo, et al.
Publicado: (2019)

A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study
por: Posocco, Bianca, et al.
Publicado: (2018)

Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer
por: Song, Wei, et al.
Publicado: (2014)

Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma
por: Zhai, Xiangyu, et al.
Publicado: (2020)

Prognostic role of serum p53 antibodies in lung cancer
por: Mattioni, Manlio, et al.
Publicado: (2015)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
por: Hofstetter, G, et al.
Publicado: (2011)

Characterization of the p53 Response to Oncogene-Induced Senescence
por: Ruiz, Lidia, et al.
Publicado: (2008)

Expression of the p53 oncogene in acute myeloblastic leukemia
Publicado: (1986)

Oncogene-mediated regulation of p53 ISGylation and functions
por: Huang, Yi-Fu, et al.
Publicado: (2014)

Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

p53 Deficiency-Dependent Oncogenicity of Runx3
por: Ito, Kosei, et al.
Publicado: (2023)

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
por: Niwa, K., et al.
Publicado: (1994)

Immunoexpression and prognostic role of p53 in different subtypes of epithelial ovarian carcinoma
por: Chen, Lihong, et al.
Publicado: (2012)

Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin
por: Miolo, Gianmaria, et al.
Publicado: (2020)

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
por: Azzalini, Eros, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_63dbfebibmg3joqiea4tota8dq